Article
Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management.
Journal of pediatric endocrinology & metabolism : JPEM - 28 Mar 2022
Giri Dinesh, Hawton Katherine, Senniappan Senthil
Abstract excerpt
Congenital hyperinsulinism (CHI) is a rare disease characterized by an unregulated insulin release, leading to hypoglycaemia. It is the most frequent cause of persistent and severe hypoglycaemia in the neonatal period and early childhood. Mutations in 16 different key genes (ABCC8, KCNJ11, GLUD1, GCK, HADH, SLC16A1, UCP2, HNF4A, HNF1A, HK1, KCNQ1, CACNA1D, FOXA2, EIF2S3, PGM1 and PMM2) that are involved in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
